178 related articles for article (PubMed ID: 29162880)
41. MSH2 rs2303425 Polymorphism is Associated with Early-Onset Breast Cancer in Taiwan.
Hsieh YC; Cho EC; Tu SH; Wu CH; Hung CS; Hsieh MC; Su CT; Liu YR; Lee CH; Ho YS; Chiou HY
Ann Surg Oncol; 2017 Feb; 24(2):603-610. PubMed ID: 26975740
[TBL] [Abstract][Full Text] [Related]
42. Association of the progesterone receptor gene with breast cancer risk: a single-nucleotide polymorphism tagging approach.
Pooley KA; Healey CS; Smith PL; Pharoah PD; Thompson D; Tee L; West J; Jordan C; Easton DF; Ponder BA; Dunning AM
Cancer Epidemiol Biomarkers Prev; 2006 Apr; 15(4):675-82. PubMed ID: 16614108
[TBL] [Abstract][Full Text] [Related]
43. Haplotype and linkage disequilibrium of TP53-WRAP53 locus in Iranian-Azeri women with breast cancer.
Pouladi N; Abdolahi S; Farajzadeh D; Hosseinpour Feizi MA
PLoS One; 2019; 14(8):e0220727. PubMed ID: 31387111
[TBL] [Abstract][Full Text] [Related]
44. The chromosomal localization, expression pattern and polymorphism analysis of porcine FSCN1 gene differently expressed from LongSAGE library.
Tang ZhL; Zhang XJ; Yang ShL; Mu YL; Cui WT; Ao H; Li K
Mol Biol Rep; 2010 Jun; 37(5):2361-7. PubMed ID: 19688270
[TBL] [Abstract][Full Text] [Related]
45. Genetic Variations of DNA Repair Genes in Breast Cancer.
Özgöz A; Hekimler Öztürk K; Yükseltürk A; Şamlı H; Başkan Z; Mutlu İçduygu F; Bacaksız M
Pathol Oncol Res; 2019 Jan; 25(1):107-114. PubMed ID: 28983784
[TBL] [Abstract][Full Text] [Related]
46. Influence of BCL2-938 C>A promoter polymorphism and BCL2 gene expression on the progression of breast cancer.
Bhushann Meka P; Jarjapu S; Vishwakarma SK; Nanchari SR; Cingeetham A; Annamaneni S; Mukta S; Triveni B; Satti V
Tumour Biol; 2016 May; 37(5):6905-12. PubMed ID: 26662799
[TBL] [Abstract][Full Text] [Related]
47. The clinical significance of FSCN1 in non-small cell lung cancer.
Luo A; Yin Y; Li X; Xu H; Mei Q; Feng D
Biomed Pharmacother; 2015 Jul; 73():75-9. PubMed ID: 26211585
[TBL] [Abstract][Full Text] [Related]
48. Association of RETN and CAP1 SNPs, Expression and Serum Resistin Levels with Breast Cancer in Mexican Women.
Muñoz-Palomeque A; Guerrero-Ramirez MA; Rubio-Chavez LA; Rosales-Gomez RC; Lopez-Cardona MG; Barajas-Avila VH; Delgadillo-Barrera A; Canton-Romero JC; Montoya-Fuentes H; Garcia-Cobian TA; Gutierrez-Rubio SA
Genet Test Mol Biomarkers; 2018 Apr; 22(4):209-217. PubMed ID: 29641286
[TBL] [Abstract][Full Text] [Related]
49. Long non-coding RNA ZEB1-AS1 regulates miR-200b/FSCN1 signaling and enhances migration and invasion induced by TGF-β1 in bladder cancer cells.
Gao R; Zhang N; Yang J; Zhu Y; Zhang Z; Wang J; Xu X; Li Z; Liu X; Li Z; Li J; Kong C; Bi J
J Exp Clin Cancer Res; 2019 Mar; 38(1):111. PubMed ID: 30823924
[TBL] [Abstract][Full Text] [Related]
50. Association of CYP2E1, STK15 and XRCC1 Polymorphisms with Risk of Breast Cancer in Malaysian Women.
Chong ET; Goh LP; See EU; Chuah JA; Chua KH; Lee PC
Asian Pac J Cancer Prev; 2016; 17(2):647-53. PubMed ID: 26925658
[TBL] [Abstract][Full Text] [Related]
51. Genetic interactions between ANLN and KDR are prognostic for breast cancer survival.
Dai X; Chen X; Hakizimana O; Mei Y
Oncol Rep; 2019 Dec; 42(6):2255-2266. PubMed ID: 31578580
[TBL] [Abstract][Full Text] [Related]
52. Genetic polymorphisms of SULT1A1 and SULT1E1 and the risk and survival of breast cancer.
Choi JY; Lee KM; Park SK; Noh DY; Ahn SH; Chung HW; Han W; Kim JS; Shin SG; Jang IJ; Yoo KY; Hirvonen A; Kang D
Cancer Epidemiol Biomarkers Prev; 2005 May; 14(5):1090-5. PubMed ID: 15894657
[TBL] [Abstract][Full Text] [Related]
53. C6ORF97-ESR1 breast cancer susceptibility locus: influence on progression and survival in breast cancer patients.
Yamamoto-Ibusuki M; Yamamoto Y; Fujiwara S; Sueta A; Yamamoto S; Hayashi M; Tomiguchi M; Takeshita T; Iwase H
Eur J Hum Genet; 2015 Jul; 23(7):949-56. PubMed ID: 25370037
[TBL] [Abstract][Full Text] [Related]
54. Breast cancer risk associated with genotypic polymorphism of the mitosis-regulating gene Aurora-A/STK15/BTAK.
Lo YL; Yu JC; Chen ST; Yang HC; Fann CS; Mau YC; Shen CY
Int J Cancer; 2005 Jun; 115(2):276-83. PubMed ID: 15688402
[TBL] [Abstract][Full Text] [Related]
55. Association of matrix metalloproteinase-8 gene variation with breast cancer prognosis.
Decock J; Long JR; Laxton RC; Shu XO; Hodgkinson C; Hendrickx W; Pearce EG; Gao YT; Pereira AC; Paridaens R; Zheng W; Ye S
Cancer Res; 2007 Nov; 67(21):10214-21. PubMed ID: 17974962
[TBL] [Abstract][Full Text] [Related]
56. T Cell Immunoglobulin- and Mucin-Domain-Containing Molecule 3 Gene Polymorphisms and Susceptibility to Invasive Breast Cancer.
Cheng S; Ju Y; Han F; Wang Y; Xu Y; Qu T; Lu Z
Ann Clin Lab Sci; 2017 Nov; 47(6):668-675. PubMed ID: 29263040
[TBL] [Abstract][Full Text] [Related]
57. Single nucleotide polymorphisms in noncoding regions of Rad51C do not change the risk of unselected breast cancer but they modulate the level of oxidative stress and the DNA damage characteristics: a case-control study.
Gresner P; Gromadzinska J; Jablonska E; Stepnik M; Zambrano Quispe O; Twardowska E; Wasowicz W
PLoS One; 2014; 9(10):e110696. PubMed ID: 25343521
[TBL] [Abstract][Full Text] [Related]
58. Significant association of combination of OCT4, NANOG, and SOX2 gene polymorphisms in susceptibility and response to treatment in North Indian breast cancer patients.
Tulsyan S; Agarwal G; Lal P; Mittal B
Cancer Chemother Pharmacol; 2014 Nov; 74(5):1065-78. PubMed ID: 25223935
[TBL] [Abstract][Full Text] [Related]
59. Oestrogen receptor alpha gene haplotype and postmenopausal breast cancer risk: a case control study.
Wedrén S; Lovmar L; Humphreys K; Magnusson C; Melhus H; Syvänen AC; Kindmark A; Landegren U; Fermér ML; Stiger F; Persson I; Baron J; Weiderpass E
Breast Cancer Res; 2004; 6(4):R437-49. PubMed ID: 15217512
[TBL] [Abstract][Full Text] [Related]
60. Common variants in the UBC9 gene encoding the SUMO-conjugating enzyme are associated with breast tumor grade.
Dünnebier T; Bermejo JL; Haas S; Fischer HP; Pierl CB; Justenhoven C; Brauch H; Baisch C; Gilbert M; Harth V; Spickenheuer A; Rabstein S; Pesch B; Brüning T; Ko YD; Hamann U
Int J Cancer; 2009 Aug; 125(3):596-602. PubMed ID: 19358266
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
